These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 29076657

  • 1. Safety profile of a replication-deficient human adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle.
    Barrera J, Brake DA, Kamicker BJ, Purcell C, Kaptur R, Schieber T, Lechtenberg K, Miller TD, Ettyreddy D, Brough DE, Butman BT, Colby M, Neilan JG.
    Transbound Emerg Dis; 2018 Apr; 65(2):447-455. PubMed ID: 29076657
    [Abstract] [Full Text] [Related]

  • 2. Efficacy of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine in cattle using a direct contact transmission model.
    Neilan JG, Schutta C, Barrera J, Pisano M, Zsak L, Hartwig E, Rasmussen MV, Kamicker BJ, Ettyreddy D, Brough DE, Butman BT, Brake DA.
    BMC Vet Res; 2018 Aug 29; 14(1):254. PubMed ID: 30157853
    [Abstract] [Full Text] [Related]

  • 3. Multiple efficacy studies of an adenovirus-vectored foot-and-mouth disease virus serotype A24 subunit vaccine in cattle using homologous challenge.
    Schutta C, Barrera J, Pisano M, Zsak L, Grubman MJ, Mayr GA, Moraes MP, Kamicker BJ, Brake DA, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2016 Jun 08; 34(27):3214-3220. PubMed ID: 26707216
    [Abstract] [Full Text] [Related]

  • 4. Use of ENABL® adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine.
    Barrera J, Schutta C, Pisano M, Grubman MJ, Brake DA, Miller T, Kamicker BJ, Olutunmbi F, Ettyreddy D, Brough DE, Butman BT, Neilan JG.
    Vaccine; 2018 Feb 14; 36(8):1078-1084. PubMed ID: 29358056
    [Abstract] [Full Text] [Related]

  • 5. Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.
    Barrera J, Brake DA, Schutta C, Ettyreddy D, Kamicker BJ, Rasmussen MV, Bravo de Rueda C, Zurita M, Pisano M, Hurtle W, Brough DE, Butman BT, Harper BG, Neilan JG.
    Vaccine; 2018 Nov 19; 36(48):7345-7352. PubMed ID: 30327212
    [Abstract] [Full Text] [Related]

  • 6. Duration of protection and humoral immunity induced by an adenovirus-vectored subunit vaccine for foot-and-mouth disease (FMD) in Holstein steers.
    Sitt T, Kenney M, Barrera J, Pandya M, Eckstrom K, Warner M, Pacheco JM, LaRocco M, Palarea-Albaladejo J, Brake D, Rieder E, Arzt J, Barlow JW, Golde WT.
    Vaccine; 2019 Sep 30; 37(42):6221-6231. PubMed ID: 31493951
    [Abstract] [Full Text] [Related]

  • 7. Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.
    Moraes MP, Segundo FD, Dias CC, Pena L, Grubman MJ.
    Vaccine; 2011 Nov 28; 29(51):9431-40. PubMed ID: 22027486
    [Abstract] [Full Text] [Related]

  • 8. Recombinant human adenovirus-5 expressing capsid proteins of Indian vaccine strains of foot-and-mouth disease virus elicits effective antibody response in cattle.
    Sreenivasa BP, Mohapatra JK, Pauszek SJ, Koster M, Dhanya VC, Tamil Selvan RP, Hosamani M, Saravanan P, Basagoudanavar SH, de Los Santos T, Venkataramanan R, Rodriguez LL, Grubman MJ.
    Vet Microbiol; 2017 May 28; 203():196-201. PubMed ID: 28619144
    [Abstract] [Full Text] [Related]

  • 9. Human adenovirus-vectored foot-and-mouth disease vaccines: establishment of a vaccine product profile through in vitro testing.
    Brake DA, McIlhaney M, Miller T, Christianson K, Keene A, Lohnas G, Purcell C, Neilan J, Schutta C, Barrera J, Burrage T, Brough DE, Butman BT.
    Dev Biol (Basel); 2012 May 28; 134():123-33. PubMed ID: 22888605
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN, Montiel N, Diaz-San Segundo F, Sturza D, Ramirez-Medina E, Grubman MJ, de los Santos T.
    Clin Vaccine Immunol; 2015 Nov 25; 23(2):125-36. PubMed ID: 26607309
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of modified Vaccinia Ankara-based vaccines against foot-and-mouth disease serotype A24 in cattle.
    Steigerwald R, Brake DA, Barrera J, Schutta CJ, Kalla M, Wennier ST, Volkmann A, Hurtle W, Clark BA, Zurita M, Pisano M, Kamicker BJ, Puckette MC, Rasmussen MV, Neilan JG.
    Vaccine; 2020 Jan 22; 38(4):769-778. PubMed ID: 31718901
    [Abstract] [Full Text] [Related]

  • 12. Delivery of a foot-and-mouth disease virus empty capsid subunit antigen with nonstructural protein 2B improves protection of swine.
    Pena L, Moraes MP, Koster M, Burrage T, Pacheco JM, Segundo FD, Grubman MJ.
    Vaccine; 2008 Oct 23; 26(45):5689-99. PubMed ID: 18762225
    [Abstract] [Full Text] [Related]

  • 13. Recombinant adenovirus co-expressing capsid proteins of two serotypes of foot-and-mouth disease virus (FMDV): in vitro characterization and induction of neutralizing antibodies against FMDV in swine.
    Wu Q, Moraes MP, Grubman MJ.
    Virus Res; 2003 Jun 23; 93(2):211-9. PubMed ID: 12782369
    [Abstract] [Full Text] [Related]

  • 14. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24.
    Moraes MP, Mayr GA, Mason PW, Grubman MJ.
    Vaccine; 2002 Feb 22; 20(11-12):1631-9. PubMed ID: 11858872
    [Abstract] [Full Text] [Related]

  • 15. Early detection and visualization of human adenovirus serotype 5-viral vectors carrying foot-and-mouth disease virus or luciferase transgenes in cell lines and bovine tissues.
    Montiel N, Smoliga G, Arzt J.
    Vaccine; 2012 Feb 21; 30(9):1690-701. PubMed ID: 22227230
    [Abstract] [Full Text] [Related]

  • 16. Adenovirus-vectored foot-and-mouth disease vaccine confers early and full protection against FMDV O1 Manisa in swine.
    Fernandez-Sainz I, Medina GN, Ramirez-Medina E, Koster MJ, Grubman MJ, de Los Santos T.
    Virology; 2017 Feb 21; 502():123-132. PubMed ID: 28039799
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z, Pan L, Ding Y, Zhou P, Lv J, Chen H, Fang Y, Liu X, Chang H, Zhang J, Shao J, Lin T, Zhao F, Zhang Y, Wang Y.
    Appl Microbiol Biotechnol; 2015 Feb 21; 99(3):1389-98. PubMed ID: 25381487
    [Abstract] [Full Text] [Related]

  • 18. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ.
    Biologicals; 2005 Dec 21; 33(4):227-34. PubMed ID: 16289996
    [Abstract] [Full Text] [Related]

  • 19. Production and application of recombinant antibodies to foot-and-mouth disease virus non-structural protein 3ABC.
    Foord AJ, Muller JD, Yu M, Wang LF, Heine HG.
    J Immunol Methods; 2007 Apr 10; 321(1-2):142-51. PubMed ID: 17328909
    [Abstract] [Full Text] [Related]

  • 20. Foot-and-mouth disease vaccination induces cross-reactive IFN-γ responses in cattle that are dependent on the integrity of the 140S particles.
    Bucafusco D, Di Giacomo S, Pega J, Schammas JM, Cardoso N, Capozzo AV, Perez-Filgueira M.
    Virology; 2015 Feb 10; 476():11-18. PubMed ID: 25496826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.